Kairos Pharma, Ltd.
KAPA
$0.48
-$0.01-2.05%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.44% | 83.75% | -16.10% | 184.28% | -60.46% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 112.50% | -72.73% | 60.00% | 44.74% | 280.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -20.06% | -38.44% | -27.83% | -16.79% | 88.71% |
| Total Current Assets | -19.07% | 37.55% | -20.02% | 45.12% | -12.08% |
|
|
|||||
| Total Current Assets | -19.07% | 37.55% | -20.02% | 45.12% | -12.08% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -39.22% | -28.17% | -21.98% | -18.02% | -15.27% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.59% | -22.70% | -0.76% | 23.82% | -- |
| Total Assets | -18.92% | 20.88% | -15.93% | 37.60% | 15.27% |
|
|
|||||
| Total Accounts Payable | -50.50% | -40.53% | -16.02% | -18.85% | -35.16% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -50.50% | -40.53% | -16.02% | -18.85% | -40.67% |
|
|
|||||
| Total Current Liabilities | -50.50% | -40.53% | -16.02% | -18.85% | -40.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -50.50% | -40.53% | -16.02% | -18.85% | -40.67% |
|
|
|||||
| Common Stock & APIC | 0.20% | 17.52% | 4.61% | 23.06% | 21.71% |
| Retained Earnings | -10.58% | -12.16% | -14.11% | -14.32% | -12.51% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -17.26% | 27.80% | -15.91% | 49.33% | 43.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.26% | 27.80% | -15.91% | 49.33% | 43.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.26% | 27.80% | -15.91% | 49.33% | 43.34% |
|
|
|||||